Iron Tryptophanate
Iron tryptophanate is a chelated iron compound theoretically formed by binding ferrous or ferric iron to the amino acid tryptophan. No peer-reviewed studies, clinical trials, or documented bioavailability data exist for this specific compound in the scientific literature.

Origin & History
Iron Tryptophanate is not a recognized or documented compound in standard chemical databases or biomedical literature. No information exists regarding its origin, extraction methods, or production processes, and it does not appear in PubChem or other chemical registries.
Historical & Cultural Context
No historical or traditional use of Iron Tryptophanate has been identified in any traditional medicine systems. The compound does not appear in any historical medical texts or traditional pharmacopeias.
Health Benefits
• No documented health benefits - compound not found in scientific literature • No clinical evidence available for any therapeutic uses • No studies exist demonstrating efficacy for any health conditions • No research has been conducted on this compound • No traditional or modern applications have been documented
How It Works
Iron tryptophanate would theoretically deliver ferrous (Fe2+) or ferric (Fe3+) iron via chelation with tryptophan, potentially utilizing divalent metal transporter 1 (DMT1) for intestinal absorption after dissociation. The tryptophan moiety might hypothetically influence serotonin or melatonin synthesis pathways, as tryptophan is a precursor to 5-hydroxytryptophan (5-HTP) via tryptophan hydroxylase. However, no published research has confirmed any specific receptor binding, enzymatic interaction, or metabolic pathway for this compound as an intact molecule.
Scientific Research
No human clinical trials, randomized controlled trials, or meta-analyses have been conducted on Iron Tryptophanate. No PubMed PMIDs exist for this compound as it is not recognized in the scientific literature.
Clinical Summary
No clinical trials, observational studies, in vitro experiments, or animal studies have been published examining iron tryptophanate as a distinct compound. A search of PubMed, ClinicalTrials.gov, and major pharmacological databases returns no results for this specific chelate. Without bioavailability data, therapeutic dosing ranges, or efficacy endpoints, no evidence-based claims can be made. The compound's therapeutic potential, if any, remains entirely uncharacterized.
Nutritional Profile
Iron Tryptophanate is a chelated mineral compound in which iron (Fe²⁺ or Fe³⁺) is coordinately bound to tryptophan (an essential amino acid, C₁₁H₁₂N₂O₂). As a chelated iron form, it theoretically delivers both elemental iron and tryptophan in a single molecular complex. The iron component contributes to the elemental iron pool relevant to hemoglobin synthesis and enzymatic function, with chelated iron forms generally demonstrating improved bioavailability compared to inorganic iron salts (e.g., ferrous sulfate) due to protection from inhibitory dietary factors like phytates and tannins. The tryptophan moiety (an aromatic amino acid precursor to serotonin and niacin) may contribute marginally to amino acid intake upon hydrolysis of the chelate bond in the gut. Exact elemental iron concentration per unit mass is not formally established in pharmacopeial literature, but chelated iron compounds typically range from 10–20% elemental iron by molecular weight. No independent fiber, fat, or carbohydrate content is present. Bioavailability data specific to this chelate form is not published in peer-reviewed literature.
Preparation & Dosage
No clinically studied dosage ranges exist for Iron Tryptophanate as no forms (extract, powder, or standardized preparations) have been documented. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Iron Tryptophanate may theoretically pair well with Vitamin C (ascorbic acid, 25–100 mg), which reduces Fe³⁺ to the more absorbable Fe²⁺ form and chelates iron in the intestinal lumen to further enhance non-heme iron uptake via a well-established ascorbate-iron absorption mechanism. Vitamin B6 (pyridoxine, 1–2 mg) and folate (400 mcg) complement the stack by supporting downstream heme synthesis pathways and red blood cell maturation, working alongside the iron component at the enzymatic level (e.g., ALA synthase activity). Additionally, since the tryptophan moiety — if cleaved — feeds into the serotonin synthesis pathway, pairing with Vitamin B6 (a cofactor for aromatic L-amino acid decarboxylase) and magnesium glycinate (100–200 mg, supporting enzymatic cofactor roles) could theoretically support both iron metabolism and serotonergic neurotransmitter production through complementary biochemical pathways.
Safety & Interactions
No formal safety studies, toxicology reports, or adverse event data exist for iron tryptophanate specifically. General iron supplementation risks include gastrointestinal distress, constipation, and iron overload in individuals with hemochromatosis; tryptophan supplements carry rare risk of eosinophilia-myalgia syndrome (EMS) at high doses. Potential drug interactions cannot be ruled out, particularly with levodopa, MAOIs, or SSRIs given tryptophan's serotonergic precursor role, but no interaction data specific to this compound exists. Pregnant or breastfeeding individuals should avoid undocumented compounds lacking safety profiles.